This systematic review is part of a series of associated Cochrane reviews on interventions for obese children and adolescents and has shown that pharmacological interventions (metformin, sibutramine, orlistat and fluoxetine) may have small effects in reduction in BMI and bodyweight in obese children and adolescents. However, many of these drugs are not licensed for the treatment of obesity in children and adolescents, or have been withdrawn.
Thirty-five children (39%) developed one or more complications at some time during follow-up, including airway compromise, compression, or functional impairment; lesion ulceration; visual obstruction or ocular compression; and infection.
In this article we lay out factors that bear on the success of clinical consultations and the maintenance of the essential clinician–parent relationship at progression or deterioration of life-limiting conditions or life-threatening illnesses.
This guideline covers the planning and management of end of life and palliative care in for infants, children and young people (aged 0–17 years) with life-limiting conditions. It aims to involve children, young people and their families in decisions about their care, and improve the support that is available to them throughout their lives.
Recent trials have questioned the benefit of early parenteral nutrition in adults. The effect of early parenteral nutrition on clinical outcomes in critically ill children is unclear.
The Nuffield Trust has published The future of child health services: new models of care. This briefing describes the current state of child health and quality of care in the UK, including problems around increasing use of hospitals to treat conditions that could be dealt with in other settings; capacity issues in primary care; and the often disjointed care provided between hospitals and the community. It then looks some examples of new models of care which have been emerging both within the Vanguard scheme and inspired by it and how they are responding to these issues.